259 related articles for article (PubMed ID: 21569495)
1. A 115-bp MethyLight assay for detection of p16 (CDKN2A) methylation as a diagnostic biomarker in human tissues.
Zhou J; Cao J; Lu Z; Liu H; Deng D
BMC Med Genet; 2011 May; 12():67. PubMed ID: 21569495
[TBL] [Abstract][Full Text] [Related]
2. Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study.
Cao J; Zhou J; Gao Y; Gu L; Meng H; Liu H; Deng D
Clin Cancer Res; 2009 Aug; 15(16):5178-83. PubMed ID: 19671846
[TBL] [Abstract][Full Text] [Related]
3. A similar effect of P16 hydroxymethylation and true-methylation on the prediction of malignant transformation of oral epithelial dysplasia: observation from a prospective study.
Liu H; Liu Z; Liu XW; Xu S; Wang L; Liu Y; Zhou J; Gu L; Gao Y; Liu XY; Shi H; Sun Z; Deng D
BMC Cancer; 2018 Sep; 18(1):918. PubMed ID: 30249192
[TBL] [Abstract][Full Text] [Related]
4. Nucleosomes correlate with in vivo progression pattern of de novo methylation of p16 CpG islands in human gastric carcinogenesis.
Lu ZM; Zhou J; Wang X; Guan Z; Bai H; Liu ZJ; Su N; Pan K; Ji J; Deng D
PLoS One; 2012; 7(4):e35928. PubMed ID: 22558275
[TBL] [Abstract][Full Text] [Related]
5. Significant impact of amount of PCR input templates on various PCR-based DNA methylation analysis and countermeasure.
Liu Z; Zhou J; Gu L; Deng D
Oncotarget; 2016 Aug; 7(35):56447-56455. PubMed ID: 27487147
[TBL] [Abstract][Full Text] [Related]
6. P16 Methylation as an Early Predictor for Cancer Development From Oral Epithelial Dysplasia: A Double-blind Multicentre Prospective Study.
Liu H; Liu XW; Dong G; Zhou J; Liu Y; Gao Y; Liu XY; Gu L; Sun Z; Deng D
EBioMedicine; 2015 May; 2(5):432-7. PubMed ID: 26137587
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction.
Lo YM; Wong IH; Zhang J; Tein MS; Ng MH; Hjelm NM
Cancer Res; 1999 Aug; 59(16):3899-903. PubMed ID: 10463578
[TBL] [Abstract][Full Text] [Related]
8. Methylation of CpG islands of p16 associated with progression of primary gastric carcinomas.
Luo D; Zhang B; Lv L; Xiang S; Liu Y; Ji J; Deng D
Lab Invest; 2006 Jun; 86(6):591-8. PubMed ID: 16534497
[TBL] [Abstract][Full Text] [Related]
9. MS-FLAG, a novel real-time signal generation method for methylation-specific PCR.
Bonanno C; Shehi E; Adlerstein D; Makrigiorgos GM
Clin Chem; 2007 Dec; 53(12):2119-27. PubMed ID: 17962364
[TBL] [Abstract][Full Text] [Related]
10. [Detection of methylation status of tumor suppressor gene p16 by methylation specific polymerase chain reaction].
Zhao Y; Zhang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Oct; 16(5):333-6. PubMed ID: 10514546
[TBL] [Abstract][Full Text] [Related]
11. A highly sensitive method for the detection of p16 methylation in the serum of colorectal cancer patients.
Nakayama G; Hibi K; Nakayama H; Kodera Y; Ito K; Akiyama S; Nakao A
Anticancer Res; 2007; 27(3B):1459-63. PubMed ID: 17595762
[TBL] [Abstract][Full Text] [Related]
12. Aberrant promoter CpG methylation as a molecular marker for disease monitoring in natural killer cell lymphomas.
Siu LL; Chan JK; Wong KF; Choy C; Kwong YL
Br J Haematol; 2003 Jul; 122(1):70-7. PubMed ID: 12823347
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
15. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
16. [Research on promoter region methylation status of tumor repressor gene P16 in human hepatocellular carcinoma by using methylation sensitive restriction enzyme and semi-nested PCR assay].
Jiang L; Qin Y; Sun ZL; Sun ZF; Wang JH; Yang LC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):53-6. PubMed ID: 17294727
[TBL] [Abstract][Full Text] [Related]
17. Methylation of p16 CpG islands associated with malignant transformation of gastric dysplasia in a population-based study.
Sun Y; Deng D; You WC; Bai H; Zhang L; Zhou J; Shen L; Ma JL; Xie YQ; Li JY
Clin Cancer Res; 2004 Aug; 10(15):5087-93. PubMed ID: 15297411
[TBL] [Abstract][Full Text] [Related]
18. Detection of p16 Promoter Hypermethylation by Methylation-Specific PCR.
Choudhury JH; Das R; Laskar S; Kundu S; Kumar M; Das PP; Choudhury Y; Mondal R; Ghosh SK
Methods Mol Biol; 2018; 1726():111-122. PubMed ID: 29468548
[TBL] [Abstract][Full Text] [Related]
19. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis.
Nuovo GJ; Plaia TW; Belinsky SA; Baylin SB; Herman JG
Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12754-9. PubMed ID: 10535995
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of methods to determine DNA methylation levels of a tumor-related microRNA gene.
Konishi Y; Hayashi H; Suzuki H; Yamamoto E; Sugisaki H; Higashimoto H
Anal Biochem; 2015 Sep; 484():66-71. PubMed ID: 25979762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
